Is HEXO a Buy Under $2?

: HEXO | HEXO Corp. News, Ratings, and Charts

HEXO – Canada-based cannabis company HEXO’s (HEXO) shares have declined in price over the past few months to their $1.60 all-time low yesterday. But can the stock rebound on the back of the promising Canadian cannabis industry? Read on.

Headquartered in Kanata, Canada, consumer packaged goods cannabis company HEXO Corp. (HEXO) produces and distributes innovative products to serve the global cannabis market. Canada legalized cannabis in 2018, and Canada’s legal adult-use cannabis market is expected to reach CAD8.62 billion ($6.97 billion) by 2026. However, the industry continues to face several restrictions.

HEXO’s shares have declined 14.5% in price over the past month and 61.5% over the past three months to close yesterday’s trading session at $1.65, after hitting its all-time low of $1.60.

Scott Cooper was appointed as the company’s new President & CEO on October 20 after its former co-founded, CEO Sebastien St-Louis, left due to a ‘strategic reorganization.’ Also, HEXO has remained unprofitable in the third quarter, and its EPS is expected to remain negative in its fiscal fourth quarter (ended July 31, 2021). So, HEXO’s near-term prospects look bleak.

Click here to check out our Cannabis Industry Report for 2021

Here are the factors that could influence HEXO’s performance in the upcoming months:

Cash Outflow for Acquisitions

HEXO acquired 48North Cannabis Corp. on September 1. On August 30, it acquired Redecan, Canada’s largest privately-owned licensed producer, for $400 million in cash and 69.70 million newly issued common shares of HEXO. Also, on June 1, HEXO acquired Zenabis Global Inc. It has made several other acquisitions over the past years, without much success; Its persistent cash outflow for acquisitions could take a toll on its already weak financials.

Unimpressive Financials

For its fiscal third quarter, ended April 30, 2021, HEXO’s net revenue decreased 31.1% sequentially to CAD22.66 million ($18.33 million). The company’s revenue from non-beverage adult-use fell 29% sequentially, due primarily to a sequential sales decline in the province of Quebec and certain production decisions. Its net loss came in at CAD20.71 million ($16.76 million), up 6.1% year-over-year. And its loss per share was CAD0.17, versus CAD0.26 in the year-ago period.

Poor Profitability

In terms of trailing-12-month gross profit margin, HEXO’s 9.72% is 82.3% lower than the 54.88% industry average. The stock’s 0.17% trailing-12-month asset turnover ratio is 52.9% lower than the 0.35% industry average. Furthermore, its trailing-12-month EBIT and EBITDA margins are negative, compared to the2.14% and 5.70% respective industry averages.

POWR Ratings Reflect Bleak Prospects

HEXO has an overall rating of F, which equates to a Strong Sell in our POWR Ratings system. The POWR Ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree. 

Our proprietary rating system also evaluates each stock based on eight distinct categories. HEXO has a D grade for Momentum, which is in sync with its 14.5% loss over the past month and 74.9% decline over the past six months.

The stock has an F grade for Quality, which is consistent with its lower-than-industry profitability ratios. HEXO’s 2.15 beta helped it earn an F grade for Stability.

Moreover, the stock has an F grade for Sentiment because analysts expect HEXO’s EPS to remain negative this year and next year.

HEXO is ranked #196 out of 202 stocks in the Medical – Pharmaceuticals industry. In addition to the POWR Rating grades I have just highlighted, we’ve also rated HEXO for Growth and Value. Click here to get all HEXO’s ratings.

Click here to checkout our Healthcare Sector Report for 2021

Bottom Line

HEXO is a low-priced stock, but we think it could be wise to avoid the stock now, given the company’s weak financials. Moreover, analysts expect its EPS to remain negative in the coming quarters.

How Does HEXO (HEXO) Stack Up Against its Peers?

While HEXO has an overall F POWR Rating, one  might want to consider taking a look at its industry peers having an A (Strong Buy) rating, such as Johnson & Johnson (JNJ), Novartis AG (NVS), and GlaxoSmithKline plc (GSK).

Click here to check out our Cannabis Industry Report for 2021


HEXO shares fell $1.65 (-100.00%) in premarket trading Friday. Year-to-date, HEXO has declined -55.16%, versus a 23.78% rise in the benchmark S&P 500 index during the same period.


About the Author: Manisha Chatterjee


Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
HEXOGet RatingGet RatingGet Rating
JNJGet RatingGet RatingGet Rating
NVSGet RatingGet RatingGet Rating
GSKGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

3 Energy Stocks Set to Soar Beyond Expectations

Given the geopolitical tensions, increasing global oil demand, and supply adjustments, the energy sector is poised for robust growth. Therefore, investors might consider investing in energy stocks TechnipFMC (FTI), Weatherford International (WFRD), and ChampionX (CHX), which are poised to exceed expectations. Keep reading…

Has Carnival (CCL) Stock Turned Into a Buy After Earnings Release?

Carnival Corporation (CCL) reported record revenue in its most recent quarter but still faces a negative bottom line. The collapse of Francis Scott Key Bridge brings more uncertainty to its financials. Given these events, what stance should one take with CCL stock? Read more to find out…

3 China Stocks Positioned for Long-Term Growth

Despite facing challenges, the Chinese economy has demonstrated resilience, as evidenced by recent robust industrial output and retail sales data. Given this outlook, it might be an opportune time to own three top-notch China stocks, JD.com, Inc. (JD), China Automotive Systems (CAAS), and Youdao, Inc. (DAO). Read on…

Investor Alert: “Buy the Rumor, Sell the News!”

Everyone knows that the Fed is going to cut rates at some point this year. That is the worst kept secret on the planet helping to explain how we keep making new highs for the for the S&P 500 (SPY). Unfortunately that creates an interesting predicament for stocks after rates are cut. Plus another hurdle in the 2024 Presidential election. Steve Reitmeister is here to share his insights on the market outlook along with a preview of his top 12 stocks to outperform. Read on for more...

Read More Stories

More HEXO Corp. (HEXO) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All HEXO News